Immunodiagnostic Market Research Report with Global Analysis and Forecast by 2028

The "Immunodiagnostic market" is expected to grow from US$ 17,948.62 million in 2021 to US$ 29,526.72 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2022 to 2028.

The increasing prevalence of infectious diseases and the growing use of point-of-care immunodiagnostics are the factors fueling the global immunodiagnostic market growth. However, factors such as inadequate treatment reimbursement scenarios are restraining the market growth.

Get a Sample PDF of report at- https://www.premiummarketinsights.com/sample/TIP00010723?utm_source=OpenPr&utm_medium=10640

The List of Companies -
1. Abbott Laboratories
2. F. Hoffmann-La Roche Ltd
3. DiaSorin SpA
4. Danaher Corp
5. Thermo Fisher Scientific Inc
6. PerkinElmer Inc
7. Shenzhen Mindray Bio-Medical Electronics Co Ltd
8. bioMerieux SA
9. Svar Life Science AB
10. Siemens Healthineers AG

Immunodiagnostics is a diagnostic methodology that primarily uses antigen-antibody reaction as its primary means of detection. Antibodies, specific for the desired antigen, can be conjugated with a radiolabel, fluorescent label, or color-forming enzyme and are used as a probe to detect it. The speed, accuracy, and simplicity of such tests have led to the development of rapid techniques for the diagnosis of diseases, microbes

Point-of-care testing (POCT) has become critical to patient-centric healthcare due to the need for rapid diagnostic results to determine accurate and faster treatment. A shift from centralized point-of-care testing to decentralized testing for chronic and infectious patients has resulted in convenient patient access to these diagnostics. The current approach to diagnosis and monitoring chronic conditions or detecting pathogens such as bacteria and viruses rely on immunoassay testing.

Advanced point-of-care devices enable rapid screening of up to three components from a single sample. Also, the point-of-care diagnostics (POCD) inclined toward mobile healthcare (mH) smart devices could revolutionize personalized healthcare monitoring and management, paving the way for next-generation POCTs. The infectious disease management can be significantly improved by POCTs, especially in developing countries where access to timely medical care is challenging and healthcare infrastructure is outdated and sparse. Additionally, the technologically developed diagnostic kits leading to fewer manual errors propel the immunodiagnostics market.

Innovative immunodiagnostic products are being developed by several market players. For instance, Thermo Fisher Scientific has developed immunodiagnostic products such as enzyme-linked immunoassay (ELISA) reagents and buffers, antibodies and detection probes, linking mechanisms, blocking buffers and detergents, detection substrates, and capture surfaces, along with services such as bioconjugation and detection. Further, on September 1, 2020, Roche launched SARS-CoV-2 Rapid Antigen Test. The Test is used in POC settings for symptomatic and asymptomatic people to help healthcare professionals identify the infection within 15 minutes.

Get Full Report@: https://www.premiummarketinsights.com/reports-tip/immunodiagnostics-market

The COVID-19 pandemic boosted the use of immunodiagnostics. According to the American Society for Clinical Pathology, in March 2020, the Cepheid Xpert Xpress SARS-CoV-2 test became the first POC COVID-19 detection assay to receive Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA).

Moreover, in oncology, an immunodiagnostic test can confirm the presence of a solid tumor by detecting known tumor-associated antigens or antibodies. Thus, the rising use of immunodiagnostics in cancer treatment is driving the immunodiagnostics market.

Product-Based Insights
Based on product, the immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. The enzyme-linked immunosorbent assays (ELISA) segment held the largest market share of US$ 9,980.87 million in 2021.On the other hand, chemiluminescence immunoassays (CLIA) is expected to witness the highest growth during the forecast period.

Clinical Indication-Based Insights
Based on clinical indication, the immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. The infectious diseases segment accounted for the largest share of the market in 2021, and it is expected to register the highest CAGR of 8.0% during the forecast period.

End User-Based Insight
Based on end user, the immunodiagnostics market is segmented into hospitals, clinics, diagnostics laboratories, academic and research institutes, and others. The hospitals segment held the largest share of the market in 2021. However, the clinics segment accounts for a CAGR of 8.5% during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the immunodiagnostics market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.

Buy Now this Report @: https://www.premiummarketinsights.com/buy/TIP00010723?utm_source=OpenPr&utm_medium=10640

TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 By Product
1.3.2 By Clinical Indication
1.3.3 By End User
1.3.4 By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Market Landscape
5. Key Market Dynamics
6. Global Analysis
7. by Product
Continued…

Other Reports:
IoT Market- Overview, Opportunities And Challenges Forecast To 2028 https://www.marketwatch.com/press-release/iot-market--overview-opportunities-and-challenges-forecast-to-2028-2023-05-19?mod=search_headline

Smart Manufacturing Market Demand, Size, Share, Industry Trend, Top Key Players Forecast 2028 https://www.marketwatch.com/press-release/smart-manufacturing-market-demand-size-share-industry-trend-top-key-players-forecast-2028-2023-05-19?mod=search_headline

A2P SMS And CPaaS Market- Global Industry Size, Outlook, Share, Demand, Manufacturers and 2028 Forecast https://www.marketwatch.com/press-release/a2p-sms-and-cpaas-market--global-industry-size-outlook-share-demand-manufacturers-and-2028-forecast-2023-05-19?mod=search_headline

Monoclonal Antibody Diagnostic Reagent Market- Industry Size, Trends, Global Growth, Insights and Forecast Research Report 2028 https://www.marketwatch.com/press-release/monoclonal-antibody-diagnostic-reagent-market--industry-size-trends-global-growth-insights-and-forecast-research-report-2028-2023-05-19?mod=search_headline

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.